Login
From:
Parent Project Muscular Dystrophy
(Uncensored)
subscribe
Dyne Therapeutics Announces Positive New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne - Parent Project Muscular Dystrophy
https://www.parentprojectmd.org/dyne-therapeutics-announces-positive-new-clinical-data-from-phase-1-2-deliver-trial-of-dyne-251-in-duchenne/
links
backlinks
Tagged with:
research
clinical trials
dyne therapeutics
dyne-251
Dyne Therapeutics, Inc. has announced positive new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne who are amenable to exon 51 skipping. DYNE-251 is an exon skipping product...
Roast topics
Find topics
Find it!
